Jan 03, 2013
1:300
For every 300 shares held, investors received 1. The price per share adjusted from $0.20 to $60.00.
The split itself did not change the total investment value.
Helix BioMedix, Inc. (OTC:HXBM) operates in the Pharmaceuticals: major industry.
Helix BioMedix, Inc. company overviewHelix BioMedix, Inc.'s most recent stock split was on January 3, 2013. It was a 1-for-300 reverse split, so shareholders received 1 share for every 300 they held.
Helix BioMedix, Inc. (OTC:HXBM) has split its stock 2 times: a 1-for-500 reverse split on January 18, 1994 and a 1-for-300 reverse split on January 3, 2013.
Helix BioMedix, Inc. has split its stock 2 times. This history records 2 reverse splits between January 18, 1994 and January 3, 2013.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Helix BioMedix, Inc.'s 1-for-300 reverse split on January 3, 2013, every 300 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Helix BioMedix, Inc. has not announced a new split in our records. Its most recent split was on January 3, 2013, 13 years ago. Companies announce splits in advance, and any new OTC:HXBM split will appear on this page.